ZHEJIANG YONGTAI TECHNOLOGY CO.,LTD. |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 8.95 CNY | -2.82% |
|
-9.87% | -22.98% |
| Feb. 02 | Yongtai Technology's Fenofibrate Capsules Get US FDA Nod | MT |
| Jan. 10 | Yongtai Technology Extends Partnership with CATL in Electrolyte Market | MT |
| Sales 2021 | 4.42B 610M | Sales 2022 | 6.32B 873M | Capitalization | 19.14B 2.64B |
|---|---|---|---|---|---|
| Net income 2021 | 280M 38.68M | Net income 2022 | 554M 76.52M | EV / Sales 2021 | 10.7 x |
| Net Debt 2021 | 2.29B 316M | Net Debt 2022 | 2.39B 331M | EV / Sales 2022 | 3.41 x |
| P/E ratio 2021 |
160
x | P/E ratio 2022 |
34.7
x | Employees | 3,887 |
| Yield 2021 |
0.2% | Yield 2022 |
0.46% | Free-Float | 69.52% |
More Fundamentals
* Assessed data
More news
| 1 day | -2.82% | ||
| 1 week | -9.87% | ||
| Current month | -13.94% | ||
| 1 month | -15.33% | ||
| 3 months | -20.09% | ||
| 6 months | -27.65% | ||
| Current year | -22.98% |
1 week
8.75
10.14
1 month
8.7511.31
Current year
7.9312.58
1 year
7.9320.55
3 years
7.9381.13
5 years
6.4381.13
10 years
3.6681.13
| Managers | Title | Age | Since |
|---|---|---|---|
Ren Bao He
FOU | Founder | 59 | 99-10-10 |
Kuang He
CEO | Chief Executive Officer | - | 19-07-10 |
Li Jie Chen
DFI | Director of Finance/CFO | 52 | 98-12-31 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Ying Mei Wang
FOU | Founder | 58 | 99-10-10 |
Ren Bao He
FOU | Founder | 59 | 99-10-10 |
Guang Liang Yang
BRD | Director/Board Member | 59 | - |
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 0.05% | 35 M€ | -5.85% | - | |
| 0.03% | 3 M€ | -6.96% | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-04-19 | 8.95 | -2.82% | 10,957,630 |
| 24-04-18 | 9.21 | -2.33% | 13,629,900 |
| 24-04-17 | 9.43 | +7.28% | 16,422,020 |
| 24-04-16 | 8.79 | -8.34% | 22,126,180 |
| 24-04-15 | 9.59 | -3.42% | 17,731,710 |
End-of-day quote Shenzhen S.E., April 18, 2024
More quotes
Zhejiang Yongtai Technology Co ., Ltd. is a China-based company principally engaged in the research, development, manufacture and distribution of fluoric fine chemical products. The Company's main products include pharmaceutical fluorine-containing intermediates, fluoride-containing intermediates of herbicides, fungicides and pesticides, pesticides and related agents, fluorine-containing single crystal intermediates, single crystal and flat panel display color filter materials, lthium hexafluorophosphate and lithium bisfluorosulfonyl imide, among others. The Company distributes its products in domestic market and to overseas markets.
Sector
Commodity Chemicals
Calendar
2024-04-25
- Q1 2024 Earnings Release
Annual profits - Rate of surprise
| 1st Jan change | Capi. | |
|---|---|---|
| -22.98% | 1.16B | |
| +6.61% | 104B | |
| -3.11% | 64.7B | |
| +12.67% | 37.83B | |
| +30.48% | 36.98B | |
| +5.95% | 32.35B | |
| +7.72% | 19.14B | |
| +15.03% | 16.7B | |
| +22.17% | 15.26B | |
| +9.37% | 15.08B |
- Stock Market
- Equities
- 002326 Stock
